PATENT CLAIM ANALYSIS

Application Number: 15768025
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["514", "210210"]

Abstract:
The invention relates to novel ferroportin inhibitors of the general formula (I) pharmaceutical compositions comprising them and the use thereof as medicaments, in particular for the prophylaxis and/or treatment of diseases caused by a lack of hepcidin or iron metabolism disorders, such as particularly iron overload states such as in particular thalassemia and hemochromatosis.

Claim (Index 19):
Compounds for the use according to any one of the preceding claims, wherein\n at least one of R 1  and R 2  is a linear or branched alkyl group \u2014[CQ] n - with Q=H or C 1 -C 4 -alkyl and n=1, 2 or 3, which is substituted with a cyclic group \u201cCycl\u201d, designated as R 2* , wherein Cycl is selected from\n optionally substituted aryl, and \n optionally substituted heteroaryl, \n and wherein n is an integer of 1 to 3; the remaining of R 1  or R 2 , designated as R 1* , is selected from\n hydrogen, and \n optionally substituted alkyl; and \n Z, R 3 , A 1 , A 2  and Ar have the meaning as defined in the preceding claims.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 91.0
- Lexical Diversity: 1.25532
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15769148', '14310254', '15517528', '14007533', '15185186']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7894545955625285
- 35 USC 102 Novelty (BERT): 0.5523089053795207
- Combined Prediction Score: 0.7657400265442277
- Mean Citation Score: 298.633386
- Max Citation Score: 422.5474
- Similarity Product: 316.18565265905863

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test